PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#oral antidiabetic ×

UPDATED
Regulatorische Updates
27. Sept. 2026•1 Min. Lesezeit
FDA Approves ANDA077370 for Generic Glimepiride Tablets
The FDA has approved application ANDA077370 for generic glimepiride tablets (1‑8 mg) manufactured by Solco Healthcare U.S., LLC and sponsored by Prinston Inc.
1